{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:48:12Z","timestamp":1780080492761,"version":"3.54.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["SKJY2021025"],"award-info":[{"award-number":["SKJY2021025"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.crad.2023.12.014","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T04:16:13Z","timestamp":1704514573000},"page":"e491-e499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["MRI-based bone marrow radiomics for predicting cytogenetic abnormalities in multiple myeloma"],"prefix":"10.1016","volume":"79","author":[{"given":"X.","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crad.2023.12.014_bib1","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1038\/leu.2009.127","article-title":"International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)","volume":"23","author":"Giralt","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.crad.2023.12.014_bib2","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1182\/blood-2002-10-3017","article-title":"Clinical and biologic implications of recurrent genomic aberrations in myeloma","volume":"101","author":"Fonseca","year":"2003","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.crad.2023.12.014_bib3","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.4065\/mcp.2009.0603","article-title":"Management of newly diagnosed symptomatic multiple myeloma: updated Mayo stratification of myeloma and risk-adapted therapy (mSMART) consensus guidelines","volume":"84","author":"Kumar","year":"2009","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"10.1016\/j.crad.2023.12.014_bib4","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1182\/blood-2010-09-307645","article-title":"Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients","volume":"117","author":"Gay","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.crad.2023.12.014_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/gcc.22894","article-title":"Significance of distinguishing 3\u2019-IGH deletion from 5\u2019-IGH deletion in multiple myeloma","volume":"60","author":"Ning","year":"2021","journal-title":"Genes Chromosom Cancer"},{"issue":"1","key":"10.1016\/j.crad.2023.12.014_bib6","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/leu.2012.160","article-title":"Improvement in long-term outcomes with successive Total Therapy trials for multiple myeloma: are patients now being cured?","volume":"27","author":"Usmani","year":"2013","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.crad.2023.12.014_bib7","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3324\/haematol.2011.056176","article-title":"European Myeloma Network. Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders","volume":"97","author":"Ross","year":"2012","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.crad.2023.12.014_bib8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2005-01-0034","article-title":"Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma","volume":"106","author":"Bergsagel","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.crad.2023.12.014_bib9","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.crad.2023.12.014_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2214\/AJR.16.17219","article-title":"A comparison of different staging systems for multiple myeloma: can the MRI pattern play a prognostic role?","volume":"209","author":"Filonzi","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.crad.2023.12.014_bib11","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1016\/j.ejrad.2012.06.028","article-title":"Contrast enhanced MRI and 18F-FDG PET-CT in the assessment of multiple myeloma: a comparison of results in different phases of the disease","volume":"81","author":"Spinnato","year":"2012","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.crad.2023.12.014_bib12","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.2214\/AJR.11.7005","article-title":"MRI of spinal bone marrow: Part 1, techniques and normal age-related appearances","volume":"197","author":"Shah","year":"2011","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.crad.2023.12.014_bib13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","article-title":"Radiomic: the bridge between medical imaging and personalized medicine","volume":"14","author":"Lambin","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.crad.2023.12.014_bib14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","article-title":"Radiomics: extracting more information from medical images using advanced feature analysis","volume":"48","author":"Lambin","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.crad.2023.12.014_bib15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomic: images are more than pictures, they are data","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.crad.2023.12.014_bib16","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/jmri.27637","article-title":"Prediction of high-risk cytogenetic status in multiple myeloma based on magnetic resonance imaging: utility of radiomics and comparison of machine learning methods","volume":"54","author":"Liu","year":"2021","journal-title":"J Magn Reson Imaging"},{"issue":"9","key":"10.1016\/j.crad.2023.12.014_bib17","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1007\/s11547-021-01388-y","article-title":"A preliminary study using spinal MRI-based radiomics to predict high-risk cytogenetic abnormalities in multiple myeloma","volume":"126","author":"Liu","year":"2021","journal-title":"Radiol Med"},{"issue":"10","key":"10.1016\/j.crad.2023.12.014_bib18","doi-asserted-by":"crossref","first-page":"7664","DOI":"10.1007\/s00330-021-07821-0","article-title":"Quantitative and qualitative assessment of plasma cell dyscrasias in dual-layer spectral CT","volume":"31","author":"Brandelik","year":"2021","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.crad.2023.12.014_bib19","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1007\/s00330-020-07320-8","article-title":"Role of computed tomography texture analysis using dual-energy-based bone marrow imaging for multiple myeloma characterization: comparison with histology and established serologic parameters","volume":"31","author":"Reinert","year":"2021","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.crad.2023.12.014_bib20","first-page":"463","article-title":"Quantitative evaluation of bone marrow infiltration using dual-energy spectral computed tomography in patients with multiple myeloma","volume":"29","author":"Hu","year":"2021","journal-title":"J Xray Sci Technol"},{"key":"10.1016\/j.crad.2023.12.014_bib21","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/cncr.10818","article-title":"Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?","volume":"95","author":"Baur","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.crad.2023.12.014_bib22","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1055\/s-2005-858362","article-title":"Correlation of MRI and histopathology of bone marrow in patients with multiple myeloma","volume":"177","author":"Wasser","year":"2005","journal-title":"RoFo"},{"issue":"13","key":"10.1016\/j.crad.2023.12.014_bib23","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1097\/00007632-199310000-00017","article-title":"The role of T2-weighted gradient echo in MRI demonstration of spinal multiple myeloma","volume":"18","author":"Avrahami","year":"1993","journal-title":"Spine (Phila Pa 1976)"},{"issue":"11","key":"10.1016\/j.crad.2023.12.014_bib24","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1007\/s00330-014-3324-5","article-title":"The diagnostic value of SE MRI and DWI of the spine in patients with monoclonal gammopathy of undetermined significance, smouldering myeloma and multiple myeloma","volume":"24","author":"Dutoit","year":"2014","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.crad.2023.12.014_bib25","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s00330-020-07295-6","article-title":"Baseline bone marrow ADC value of diffusion-weighted MRI: a potential independent predictor for progression and death in patients with newly diagnosed multiple myeloma","volume":"31","author":"Zhang","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2023.12.014_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2019.108695","article-title":"Whole-body diffusion-weighted MRI for evaluation of response in multiple myeloma patients following bortezomib-based therapy: a large single-center cohort study","volume":"120","author":"Zhang","year":"2019","journal-title":"Eur J Radiol"},{"issue":"6","key":"10.1016\/j.crad.2023.12.014_bib27","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1007\/s00261-019-02028-w","article-title":"Radiogenomics: bridging imaging and genomics","volume":"44","author":"Bodalal","year":"2019","journal-title":"Abdom Radiol (NY)"},{"issue":"6","key":"10.1016\/j.crad.2023.12.014_bib28","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.3390\/jcm12062280","article-title":"Machine learning model based on optimized radiomics feature from 18F-FDG-PET\/CT and clinical characteristics predicts prognosis of multiple myeloma: a preliminary study","volume":"12","author":"Ni","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.crad.2023.12.014_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12880-023-01033-2","article-title":"18F-FDG PET\/CT based radiomics features improve prediction of prognosis: multiple machine learning algorithms and multimodality applications for multiple myeloma","volume":"23","author":"Zhong","year":"2023","journal-title":"BMC Med Imaging"},{"key":"10.1016\/j.crad.2023.12.014_bib30","doi-asserted-by":"crossref","unstructured":"Jamet B, Morvan L, Nanni C, et\u00a0al. Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials. Eur J Nucl Med Mol Imaging 202; 48(4):1005-1015.","DOI":"10.1007\/s00259-020-05049-6"},{"issue":"8","key":"10.1016\/j.crad.2023.12.014_bib31","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1007\/s00330-023-09540-0","article-title":"Lumbar MR-based radiomics nomogram for detecting minimal residual disease in patients with multiple myeloma","volume":"33","author":"Wu","year":"2023","journal-title":"Eur Radiol"},{"issue":"39","key":"10.1016\/j.crad.2023.12.014_bib32","doi-asserted-by":"crossref","first-page":"65435","DOI":"10.18632\/oncotarget.18918","article-title":"Quantitative evaluation of Gd-EOB-DTPA uptake in focal liver lesions by using T1 mapping: differences between hepatocellular carcinoma, hepatic focal nodular hyperplasia and cavernous hemangioma","volume":"8","author":"Peng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.crad.2023.12.014_bib33","first-page":"7","article-title":"Cancer statistics","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926024000072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926024000072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:13:52Z","timestamp":1762114432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926024000072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0009926024000072"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2023.12.014","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MRI-based bone marrow radiomics for predicting cytogenetic abnormalities in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2023.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}